ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,407Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 1278

$861K Total Retail Price of All Prescriptions

Rank: 24 out of 1278

877 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 877 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 877 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 11,301 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 931 728 1 1
METFORMIN HCL 713 553 2 4
PRAVASTATIN SODIUM 656 499 3 14
LEVOTHYROXINE SODIUM 489 404 4 2
SIMVASTATIN 461 354 5 3
LOVASTATIN 404 319 6 13
METOPROLOL TARTRATE 376 301 7 9
HYDROCODONE-ACETAMINOPHEN 346 221 S3 8 7
GLIMEPIRIDE 320 302 9 61
AMLODIPINE BESYLATE 318 267 10 5
OMEPRAZOLE 310 234 11 6
ATENOLOL 240 204 12 11
LANTUS 212 110 13 33
ATORVASTATIN CALCIUM 210 175 14 15
CRESTOR 208 161 15 31
FENOFIBRATE 205 128 16 47
ALENDRONATE SODIUM 198 162 17 18
MELOXICAM 194 140 18 57
TRAMADOL HCL 180 124 19 25
AMITRIPTYLINE HCL 180 105 R 19 55
HYDROCHLOROTHIAZIDE 174 140 21 8
FUROSEMIDE 171 123 22 10
LOSARTAN POTASSIUM 171 136 22 19
INSULIN SYRINGE 157 112 24 50
EVISTA 153 135 25 99
CITALOPRAM HBR 149 109 26 22
GABAPENTIN 149 103 26 12
ACTOS 135 102 28 72
PREDNISONE 134 87 29 52
RANITIDINE HCL 130 94 30 20
CLOPIDOGREL 115 101 31 45
DIOVAN 111 86 32 44
ACETAMINOPHEN-CODEINE 105 45 S3 33 98
ALLOPURINOL 103 79 34 36
WARFARIN SODIUM 100 52 35 17
TERAZOSIN HCL 98 78 36 59
DONEPEZIL HCL 97 97 37 48
OXYCODONE-ACETAMINOPHEN 97 59 S2 37 29
PROAIR HFA 97 61 37 26
OXYCODONE HCL-ACETAMINOPHEN 96 47 S2 40 76
IBUPROFEN 95 42 41 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 67 41 30
CARVEDILOL 93 64 43 39
TRIAMTERENE-HCTZ 88 70 44 43
GEMFIBROZIL 87 67 45 54
NEXIUM 76 46 46 106
VERAPAMIL ER 76 38 46 84
CYCLOBENZAPRINE HCL 75 43 R 48 62
METOPROLOL SUCCINATE 75 61 48 23
ZOLPIDEM TARTRATE 75 50 48 16
PLAVIX 70 48 51 64
PANTOPRAZOLE SODIUM 69 58 52 34
CIMETIDINE 68 52 53 310
NADOLOL 68 64 53 225
FLUTICASONE PROPIONATE 67 52 55 24
SERTRALINE HCL 66 54 56 28
ESTRADIOL 66 47 R 56 71
TRIAMTERENE-HYDROCHLOROTHIAZID 64 33 58 129
METHOCARBAMOL 63 28 R 59 120
NYSTATIN-TRIAMCINOLONE 62 26 60 179
TAMSULOSIN HCL 61 59 61 32
MORPHINE SULFATE ER 61 0 S2 61 42
NOVOLIN N 60 51 63 270
LOSARTAN-HYDROCHLOROTHIAZIDE 60 48 63 75
JANUVIA 59 43 65 68
OXYCODONE HCL 58 24 S2 66 27
POTASSIUM CHLORIDE 56 40 67 21
HYDROXYCHLOROQUINE SULFATE 56 25 67 334
LYRICA 55 28 69 104
PIOGLITAZONE HCL 54 44 R 70 188
NAPROXEN 52 42 71 70
ISOSORBIDE MONONITRATE ER 51 38 72 96
NAMENDA 51 51 72 77
CYMBALTA 51 16 72 67
PEN NEEDLE 50 41 75 154
AZITHROMYCIN 50 28 75 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 24 75 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.